Psychiatric Disorders after Switching to Dolutegravir: A Case Report of a 59-Year-Old Virosuppressed HIV-1 Positive Woman

We report a case of a woman who experienced psychiatric disorders after switching her antiretroviral therapy (c-ART) to dolutegravir (DTG). She is a 59-year-old HIV-1 positive woman with a recent story of cardiovascular disorders treated with beta-blockers, clopidogrel, and rosuvastatin. She underwe...

Full description

Bibliographic Details
Main Authors: Daniele Mengato, Raffaella Binazzi, Ivan Unterholzner, Elke M. Erne, Alicia Tavella
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:Case Reports in Infectious Diseases
Online Access:http://dx.doi.org/10.1155/2020/9708913